Welcome to our dedicated page for Astrana Health news (Ticker: ASTH), a resource for investors and traders seeking the latest updates and insights on Astrana Health stock.
Astrana Health Inc. reports developments in physician-centric, technology-enabled healthcare management, including its care delivery infrastructure, proprietary technology platform, and aligned provider networks. The company describes a payer-agnostic, risk-bearing care model designed around coordinated, preventive care and population health management.
Recurring news themes include quarterly and annual financial results, medical cost performance, full-risk contract activity, integration of completed acquisitions, investor-conference presentations, and updates involving governance, capital structure, and operating performance. Company materials also discuss its Care Partners, Care Delivery, and Care Enablement segments.
Astrana Health (NASDAQ: ASTH) appointed George Christides, M.D. as Interim National Medical Director, effective May 12, 2026. He will oversee population health, care management, and care navigation initiatives across Astrana’s national platform.
Dr. Christides brings 20+ years of clinical and healthcare leadership experience in value-based care and managed care operations.
Astrana Health (NASDAQ: ASTH) and the Physician Association of California announced a collaboration to support independent primary care physicians using Astrana's AI-powered Medicare ACO platform.
The partnership offers PAC physicians integrated care delivery, data, and financial infrastructure, aiming to improve outcomes, ease administrative burden, and enable participation in value-based care.
Astrana Health (NASDAQ: ASTH) reported Q1 2026 results: total revenue $965.1M (+56% YoY), adjusted EBITDA $66.3M (+82% YoY), net income $14.4M (+116% YoY) and free cash flow $64.1M (+372% YoY). The company said ~80% of Care Partners capitation revenue and ~40% of consolidated membership are now in full-risk arrangements. Guidance reiterated for 2026: total revenue $3.8B–$4.1B and adjusted EBITDA $250M–$280M; Q2 revenue guidance $965M–$1,000M and adjusted EBITDA $65M–$70M.
Astrana Health (NASDAQ: ASTH) will release first quarter 2026 financial results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The company will host a conference call the same day at 2:30 p.m. PT / 5:30 p.m. ET to discuss results.
Dial-in numbers are 877-858-9810 and +1 201-689-8517. A PDF slide presentation will be posted on the company’s IR Calendar and a live webcast plus recording will be available via the provided webcast link.
Astrana Health (NASDAQ: ASTH) announced that company leadership will participate in three upcoming investor conferences: the Needham Virtual Healthcare Conference (April 13-16, 2026), the Bank of America Global Healthcare Conference (May 12-14, 2026) with a fireside chat on May 12 at 3:40pm PT, and the William Blair Growth Stock Conference (June 2-4, 2026) with a fireside chat on June 3 at 4:00pm CT.
Webcast links and presentation materials will be posted in the IR Calendar on the company website.
Foothill Regional Medical Center (NASDAQ: ASTH) received the 2026 Patient Safety Excellence Award™ from Healthgrades, placing it among the top 5% of U.S. hospitals for patient safety. The hospital earned multiple 2025–2026 Healthgrades distinctions, including joint replacement and five-star ratings across several procedures.
Foothill Regional has been a Patient Safety Excellence recipient four consecutive years (2023–2026) and operates a 177-bed acute care facility with 42 pediatric subacute beds in Orange County.
Astrana Health (NASDAQ: ASTH) announced that company leadership will participate in multiple investor conferences in March 2026, including TD Cowen (Boston), Jefferies Value-Based Healthcare (Miami), Barclays (Miami), KeyBanc (virtual) and Oppenheimer (virtual).
Each participation includes scheduled fireside chats and the company said webcast links and presentation materials will be available in the IR Calendar on its investor website.
Astrana Health (NASDAQ: ASTH) reported 2025 total revenue of $3,181.8 million, up 56% year-over-year, adjusted EBITDA of $205.4 million, and free cash flow of $104.5 million. Fourth-quarter revenue was $950.5 million with adjusted EBITDA of $52.5 million. The company filed a Form 12b-25 extension for its 2025 Form 10-K due to a material weakness in internal controls related to acquisition and purchase accounting. The Board increased the share repurchase authorization to $100 million. 2026 guidance targets ~24% revenue growth midpoint and adjusted EBITDA growth at midpoint.
Astrana Health (NASDAQ: ASTH) will release its fourth quarter and full-year 2025 financial results before market open on Monday, March 2, 2026. The company will host a conference call the same day at 5:30 a.m. PT / 8:30 a.m. ET to discuss results. A slide presentation (PDF) will be posted to the IR Calendar page after the release. The call is accessible by dial-in or live webcast, and a recording will be available after the call.
Astrana Health (NASDAQ: ASTH) announced that company leadership will participate in the J.P. Morgan 2026 Healthcare Conference in San Francisco on Monday, January 12, 2026, including a presentation at 5:15 PM PT. The company said a live webcast and related presentation materials will be posted in the IR Calendar on its investor relations website.
Investors can access the webcast and slides via the company's investor relations page at https://ir.astranahealth.com/news-events/ir-calendar.